SILVERARC CAPITAL MANAGEMENT, LLC Alnylam Pharmaceuticals, Inc. Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$0
portfolio value

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 32.54K shares 6.51M $200.16 32.54K
Q3 2022 call Decrease -100.00% -40K shares -5.83M $200.16 0
Q2 2022 call Increase 0.00% 40K shares 5.83M $145.85 40K